We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
219 hedge funds and large institutions have $4.11B invested in Acadia Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 82 increasing their positions, 69 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
19% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 69
18% more capital invested
Capital invested by funds: $3.5B → $4.11B (+$614M)
9% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 34
1.59% less ownership
Funds ownership: 100.05% → 98.47% (-1.6%)
3% less funds holding
Funds holding: 225 → 219 (-6)
24% less call options, than puts
Call options by funds: $52M | Put options by funds: $68.7M
Holders
219
Holders Change
-6
Holders Change %
-2.67%
% of All Funds
5.45%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
37
Increased
82
Reduced
69
Closed
34
Calls
$52M
Puts
$68.7M
Net Calls
-$16.6M
Net Calls Change
-$22.7M
Top Buyers
| 1 |
BlackRock
New York
|
+$188M |
| 2 |
O
OrbiMed
New York
|
+$41.3M |
| 3 |
EM
Elliott Management
New York
|
+$27.4M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$17.9M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$66.6M |
| 2 |
Jennison Associates
New York
|
-$39.6M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$37.7M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$33.5M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$20M |
